Skip to main content
. 2023 Sep 25;13(19):3043. doi: 10.3390/diagnostics13193043

Figure 2.

Figure 2

Association between KRAS mutation status and survival in non-small cell lung cancer. (A) Overall Survival for KRAS G12C mutant tumors versus other KRAS mutant tumors. Association between KRAS mutation status and survival in non-small cell lung cancer [36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51] (B). Disease-free survival for KRAS G12C mutant tumors versus other KRAS mutant tumors [40,42,46,47,49].